154 related articles for article (PubMed ID: 29805684)
21. F-18 FDG hypermetabolism in mass-forming focal pancreatitis and old hepatic schistosomiasis with granulomatous inflammation misdiagnosed by PET/CT imaging.
Ye S; Wang WL; Zhao K
Int J Clin Exp Pathol; 2014; 7(9):6339-44. PubMed ID: 25337288
[TBL] [Abstract][Full Text] [Related]
22. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Value of Dynamic
Li G; Yang S; Wang S; Jiang R; Xu X
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568893
[TBL] [Abstract][Full Text] [Related]
24. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
25. Comparing the clinical value of baseline [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
[TBL] [Abstract][Full Text] [Related]
26. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
27. Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case.
Nishi M; Ikegami T; Imura S; Morine Y; Kanemura H; Mori H; Arakawa Y; Hanaoka J; Sugimoto K; Shimada M
Surg Today; 2009; 39(2):157-61. PubMed ID: 19198997
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic sarcomatoid carcinoma: CT, MRI, and
Zhao S; Su W; Deng L; Chen Y; Zuo C; Shao C; Ren F
Clin Radiol; 2020 May; 75(5):397.e7-397.e14. PubMed ID: 32044096
[TBL] [Abstract][Full Text] [Related]
29. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
Chen YK; Su CT; Chi KH; Cheng RH; Wang SC; Hsu CH
J Nucl Med; 2007 Jan; 48(1):8-14. PubMed ID: 17204693
[TBL] [Abstract][Full Text] [Related]
30. Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
Ohtani M; Ofuji K; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Takahashi K; Naito T; Matsuda H; Hiramatsu K; Nakamoto Y
Pancreas; 2021 Aug; 50(7):1014-1019. PubMed ID: 34629452
[TBL] [Abstract][Full Text] [Related]
31. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
[TBL] [Abstract][Full Text] [Related]
32. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
[TBL] [Abstract][Full Text] [Related]
33. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
34. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
35. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of
Akcam AT; Teke Z; Saritas AG; Ulku A; Guney IB; Rencuzogullari A
Ann Surg Treat Res; 2020 Apr; 98(4):184-189. PubMed ID: 32274366
[TBL] [Abstract][Full Text] [Related]
37. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis.
Kato K; Nihashi T; Ikeda M; Abe S; Iwano S; Itoh S; Shimamoto K; Naganawa S
Clin Nucl Med; 2013 Jun; 38(6):417-21. PubMed ID: 23486318
[TBL] [Abstract][Full Text] [Related]
38. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
39. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
